V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240015380 | 240008685 | null | 54.7 | Curative (C) | 2015-12-06 | 2016-07-13 | Cytarabine intrathecal | Y | N | 240009723 | CARBOPLATIN + TOPOTECAN |
| 240015381 | 240014496 | 1.81 | 64.6 | Curative (C) | 2015-07-21 | 2015-07-22 | UKALL14- Intens/CNS Proph | 2 | N | 240009959 | CARMUSTINE + THIOTEPA |
| 240015382 | 240012637 | 1.71 | 67.1 | Adjuvant (A) | 2015-06-23 | 2015-06-23 | TOPOTECAN | 2 | N | 240009989 | UKALL60+ |
| 240015383 | 240008693 | 1.63 | 66 | Palliative (P) | 2018-06-13 | 2018-07-30 | ICE-R (Cycle 2 onwards) | N | N | 240010103 | TOPOTECAN |
| 240015384 | 240012640 | 0 | 119 | Disease modification (D) | 2015-08-24 | 2015-10-10 | Vinorelbine (oral) | Y | null | 240010288 | CISPLATIN + GEMCITABINE |
| 240015385 | 240008696 | 0 | 57 | Disease modification (D) | 2019-10-05 | 2019-10-08 | MABCUTE TRIAL | 02 | N | 240010391 | OFATUMUMAB |
| 240015386 | 240008701 | 1.68 | 65.1 | Disease modification (D) | 2018-10-19 | 2019-02-15 | IMATINIB | N | N | 240010545 | NHL 2003 |
| 240015387 | 240008705 | null | null | Curative (C) | 2017-10-22 | 2017-11-18 | CVP | N | N | 240011182 | TOPOTECAN |
| 240015388 | 240008712 | 1.68 | 65 | Palliative (P) | 2018-12-02 | 2018-12-04 | Topotecan (intravenous) | N | null | 240011523 | CVD |
| 240015389 | 240008714 | 1.54 | 58 | Curative (C) | 2018-05-10 | 2018-05-17 | CAV | 2 | N | 240011523 | CYTARABINE + METHOTREXATE HD |
| 240015390 | 240015435 | 1.52 | 50.8 | Curative (C) | 2016-10-28 | 2016-10-28 | ALL UKALL60+ TRIAL | N | N | 240011596 | CYCLOPHOSPHAMIDE + ETOPOSIDE |
| 240015391 | 240008718 | null | 82.3 | Curative (C) | 2016-12-15 | 2016-12-15 | IVE-R | N | N | 240011643 | THALIDOMIDE |
| 240015392 | 240008720 | 1.65 | 57.7 | Adjuvant (A) | 2016-12-21 | 2016-12-21 | Oxaliplatin + Raltitrexed | 02 | null | 240011697 | TEMOZOLOMIDE |
| 240015393 | 240015917 | null | 83 | null | 2016-09-18 | 2016-09-20 | CHLVPP | N | N | 240011773 | CODOX M |
| 240015394 | 240008731 | null | 59.9 | Palliative (P) | null | 2016-01-09 | R CODOX M | Y | N | 240012317 | BEVACIZUMAB + CARBO + DOCETAXEL |
| 240015395 | 240008732 | null | 60.1 | Palliative (P) | 2018-09-07 | 2018-09-10 | Ifosfamide | 2 | N | 240012325 | TOPOTECAN |
| 240015396 | 240008735 | 1.66 | 51 | Neo-adjuvant (N) | 2017-12-20 | 2018-01-17 | Bevacizumab + Paclitaxel | N | N | 240012407 | AML18 TRIAL |
| 240015397 | 240008737 | 1.63 | 60.1 | Curative (C) | 2017-03-29 | 2017-03-31 | VEDex | N | null | 240012421 | IGEV R |
| 240015398 | 240008741 | 1.71 | 91.6 | Palliative (P) | 2017-05-13 | 2017-05-13 | PEMBROLIZUMAB | N | null | 240012479 | FLUDARABINE |
| 240015399 | 240008742 | 1.66 | 47 | Palliative (P) | 2017-01-11 | 2017-01-14 | Cyclophosphamide + Etoposide (PO) | N | N | 240012886 | THALIDOMIDE |
| 240015400 | 240008745 | 1.58 | 65 | Palliative (P) | 2020-04-23 | 2020-04-23 | VEDex | N | N | 240013365 | BEVACIZUMAB + CARBO + GEMCITABINE |
| 240015401 | 240008747 | 1.55 | 80.6 | Palliative (P) | 2018-04-20 | 2018-05-11 | Vinorelbine IV | N | N | 240013846 | R CODOX M |
| 240015402 | 240008750 | 1.61 | 49.5 | Curative (C) | 2014-05-28 | 2014-05-30 | CISPLATIN + FLUOROURACIL | N | N | 240013888 | VINORELBINE |
| 240015403 | 240008754 | 1.66 | 65 | Adjuvant (A) | 2017-12-09 | 2018-07-07 | NHL 2003 Gp C M2 & 4 | 02 | N | 240014317 | REMODL TRIAL |
| 240015404 | 240008758 | 1.54 | 83 | Neo-adjuvant (N) | 2017-06-22 | 2017-07-07 | PEMBROLIZUMAB | N | N | 240014619 | VINORELBINE |
| 240015405 | 240008760 | null | null | Curative (C) | 2017-10-04 | 2017-10-14 | CARBOPLATIN + RT | null | N | 240014722 | TRIPLE INTRATHECAL |
| 240015406 | 240008762 | 1.78 | 84.3 | Curative (C) | 2017-08-11 | 2017-09-06 | GALLIUM TRIAL | N | N | 240014781 | IVE |
| 240015407 | 240008764 | null | 104 | Curative (C) | 2018-08-06 | 2018-08-06 | GEM-P | N | N | 240015091 | CLADRIBINE |
| 240015408 | 240012682 | null | 70.8 | Adjuvant (A) | null | 2016-10-10 | Capecitabine | N | N | 240015306 | DOXORUBICIN |
| 240015409 | 240008769 | 1.63 | 40 | Neo-adjuvant (N) | 2015-07-25 | 2015-07-28 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | N | 240015521 | RATHL TRIAL |
| 240015410 | 240012685 | 1.65 | 71.6 | Curative (C) | 2018-12-16 | 2018-12-18 | Ofatumumab Loading | N | N | 240015692 | CYCLOPHOSPHAMIDE + ETOPOSIDE + RITUXIMAB |
| 240015411 | 240012687 | 1.64 | null | Palliative (P) | 2017-11-17 | 2017-11-23 | EC | N | N | 240016012 | CARBOPLATIN + DOCETAXEL |
| 240015412 | 240008778 | 1.72 | 92.4 | Curative (C) | 2018-04-23 | 2018-04-27 | AML18 PILOT TRIAL | N | N | 240016111 | DOXORUBICIN + OLARATUMAB |
| 240015413 | 240008782 | 1.63 | null | Curative (C) | 2018-10-12 | 2018-10-13 | Carboplatin + Docetaxel | N | N | 240016330 | TRIPLE INTRATHECAL |
| 240015414 | 240012693 | 1.68 | 50.9 | Disease modification (D) | 2016-07-05 | 2016-07-05 | ATG + Busulfan + Fludarabine | 02 | N | 240016504 | CARBOPLATIN + RT |
| 240015415 | 240008787 | 1.65 | 62.45 | Palliative (P) | 2016-09-10 | 2016-09-10 | LENALIDOMIDE + RITUXIMAB | N | N | 240016548 | ETOPOSIDE |
| 240015416 | 240008790 | null | null | Palliative (P) | 2015-12-26 | 2016-03-17 | CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE + MESNA + RITUXIMAB | 02 | N | 240017071 | CVP |
| 240015417 | 240012697 | 1.66 | null | null | 2018-01-27 | 2018-02-04 | Nilotinib | N | null | 240017201 | CARBOPLATIN + TOPOTECAN |
| 240015418 | 240008795 | 0 | 65.4 | Palliative (P) | 2018-01-01 | 2018-01-02 | Liposomal Doxorubicin (Caelyx) | 2 | N | 240017293 | ICE-R |
| 240015419 | 240008801 | 1.63 | 114 | Curative (C) | 2018-02-21 | 2018-02-23 | DACARBAZINE + DOXORUBICIN + VINBLASTINE | 2 | N | 240017716 | AML18 TRIAL |
| 240015420 | 240008806 | 1.65 | 58 | Disease modification (D) | 2016-08-22 | 2016-08-22 | Carboplatin + Topotecan | 01 | Y | 240018081 | BUSULPHAN + FLUDARABINE |
| 240015421 | 240012705 | 1.63 | 77.5 | Disease modification (D) | 2015-08-29 | 2015-09-11 | Cytarabine High Dose | N | N | 240018318 | BEVACIZUMAB + CISPLATIN + PACLITAXEL |
| 240015422 | 240012707 | 1.8 | 63.5 | Disease modification (D) | 2018-11-27 | 2018-11-27 | GEMCITABINE + OXALIPLATIN + RITUXIMAB | N | N | 240018715 | CARMUSTINE + THIOTEPA |
| 240015423 | 240008816 | 1.64 | 49 | Palliative (P) | 2018-12-14 | 2019-03-20 | VEDex | 02 | null | 240019224 | RCEOP |
| 240015424 | 240015929 | 1.52 | null | Disease modification (D) | 2018-02-05 | 2018-02-20 | RUXOLITINIB | N | N | 240019353 | LENALIDOMIDE + RITUXIMAB |
| 240015425 | 240008820 | 1.65 | 80.1 | Curative (C) | 2016-09-16 | 2016-09-23 | ICE-R | 2 | null | 240019431 | TRIFLURIDINE + TIPIRACIL |
| 240015426 | 240015455 | 1.48 | 69.1 | Curative (C) | 2020-02-10 | 2020-02-16 | Ofatumumab Loading | 2 | N | 240019968 | CYTARABINE HIGH DOSE |
| 240015427 | 240008828 | 1.78 | 73.2 | Curative (C) | 2018-02-27 | 2018-03-05 | Docetaxel 100mg/m2 (21 day) | N | N | 240019983 | GEMCITABINE + PACLITAXEL |
| 240015428 | 240008832 | 1.59 | 50 | Palliative (P) | 2017-01-04 | 2017-01-05 | ALEMTUZUMAB + BUSULFAN + FLUDARABINE | N | N | 240020325 | PONATINIB |
| 240015429 | 240012717 | 0 | 63.4 | Curative (C) | 2015-06-20 | 2015-09-06 | ICE (no GCSF) | N | null | 240020386 | ESHAP |